Search Results

Insulin secretion decline in Walker-256 tumor-bearing rats is early, follows the course of cachexia, and is not improved by lixisenatide.

• Authors : Quintilhano DL; Department of Physiological Sciences, State University of Londrina, Londrina, PR, 86051-990, Brazil.; Miksza DR

Subjects: Cachexia/Cachexia/Cachexia/*drug therapy ; Hypoglycemic Agents/Hypoglycemic Agents/Hypoglycemic Agents/*therapeutic use ; Insulin Secretion/Insulin Secretion/Insulin Secretion/*drug effects

• Source: Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2021 Apr; Vol. 394 (4), pp. 697-705. Date of Electronic Publication: 2020 Oct 31.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0326264 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Lixisenatide requires a functional gut-vagus nerve-brain axis to trigger insulin secretion in controls and type 2 diabetic mice.

• Authors : Charpentier J; Institut National de la Santé et de la Recherche Médicale , Toulouse , France.; Université Paul Sabatier, Unité Mixte de Recherche 1048, Institut des Maladies Métaboliques et Cardiovasculaires, Toulouse Cedex, France.

Subjects: Insulin Secretion*; Brain Stem/Brain Stem/Brain Stem/*physiopathology ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy

• Source: American journal of physiology. Gastrointestinal and liver physiology [Am J Physiol Gastrointest Liver Physiol] 2018 Nov 01; Vol. 315 (5), pp. G671-G684. Date of Electronic Publisher: American Physiological Society Country of Publication: United States NLM ID: 100901227 Publication Model: Print-Electronic Cited Medium:

Record details

AWRK6, a Novel GLP-1 Receptor Agonist, Attenuates Diabetes by Stimulating Insulin Secretion.

• Authors : Wang Q; School of Life Science, Liaoning University, Shenyang 110036, China. .; Zhao C

Subjects: Insulin Secretion*; Diabetes Mellitus, Experimental/Diabetes Mellitus, Experimental/Diabetes Mellitus, Experimental/*drug therapy ; Glucagon-Like Peptide-1 Receptor/Glucagon-Like Peptide-1 Receptor/Glucagon-Like Peptide-1 Receptor/*agonists

• Source: International journal of molecular sciences [Int J Mol Sci] 2018 Oct 07; Vol. 19 (10). Date of Electronic Publication: 2018 Oct 07.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

Viscothionin purified from mistletoe (Viscum album var. coloratum Ohwi) induces insulin secretion from pancreatic beta cells.

• Authors : Park JH; Advanced Radiation Technology Institute, Korea Atomic Energy Research Institute, Jeongeup 580-185, Republic of Korea. Electronic address: .; Kim YN

Subjects: Insulin Secretion/Insulin Secretion/Insulin Secretion/*drug effects ; Insulin-Secreting Cells/Insulin-Secreting Cells/Insulin-Secreting Cells/*drug effects ; Peptides/Peptides/Peptides/*pharmacology

• Source: Journal of ethnopharmacology [J Ethnopharmacol] 2019 Apr 24; Vol. 234, pp. 172-179. Date of Electronic Publication: 2019 Jan 17.Publisher: Elsevier Sequoia Country of Publication: Ireland NLM ID: 7903310 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Adropin suppresses insulin expression and secretion in INS-1E cells and rat pancreatic islets.

• Authors : Billert M; Department of Animal Physiology, Biochemistry and Biostructure, Poznan University of Life Sciences, Poznan, Poland.; Jasaszwili M

Subjects: Blood Proteins/Blood Proteins/Blood Proteins/*pharmacology ; Insulin/Insulin/Insulin/*metabolism ; Insulin Antagonists/Insulin Antagonists/Insulin Antagonists/*pharmacology

• Source: Journal of physiology and pharmacology : an official journal of the Polish Physiological Society [J Physiol Pharmacol] 2020 Feb; Vol. 71 (1). Date of Electronic Publication: 2020 Publisher: Polish Physiological Society Country of Publication: Poland NLM ID: 9114501 Publication Model: Print-Electronic Cited Medium: Internet

Record details

PEP-1-paraoxonase 1 fusion protein prevents cytokine-induced cell destruction and impaired insulin secretion in rat insulinoma cells.

• Authors : Lee SJ; Department of Physiology, College of Medicine, Hallym University, Chuncheon 24252, Korea.; Kang HK

Subjects: Apoptosis/Apoptosis/Apoptosis/*drug effects ; Aryldialkylphosphatase/Aryldialkylphosphatase/Aryldialkylphosphatase/*pharmacology ; Cysteamine/Cysteamine/Cysteamine/*analogs & derivatives

• Source: BMB reports [BMB Rep] 2018 Oct; Vol. 51 (10), pp. 538-543.Publisher: Korean Society for Biochemistry and Molecular Biology Country of Publication: Korea (South) NLM ID: 101465334 Publication Model: Print Cited

Record details

Effects of lixisenatide treatment on mild cachexia and related metabolic abnormalities in Walker-256 tumour-bearing rats.

• Authors : Quintilhano DL; Department of Physiological Sciences, State University of Londrina, Londrina, Brazil.; Miksza DR

Subjects: Hypoglycemic Agents/Hypoglycemic Agents/Hypoglycemic Agents/*pharmacology ; Insulin Secretion/Insulin Secretion/Insulin Secretion/*drug effects ; Peptides/Peptides/Peptides/*pharmacology

• Source: Cell biochemistry and function [Cell Biochem Funct] 2021 Mar; Vol. 39 (2), pp. 335-343. Date of Electronic Publication: 2020 Sep 10.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8305874 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Agricola

Record details

Sustained hyperglycemia specifically targets translation of mRNAs for insulin secretion

• Authors : Cheruiyot, Abigael; Hollister-Lock, Jennifer; Sullivan, Brooke

• Source: Journal of Clinical Investigation. February, 2024, Vol. 134 Issue 3

Record details

Agricola

Record details